Investors in QUOSA
QUOSA has secured backing from 1 investor. Prominent investors backing the company include Elsevier.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Information solutions for science, health, and technology professionals are provided. | 1880 | elsevier.com | Amsterdam, Netherlands |
Investor details for QUOSA
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of QUOSA
2 dated milestones of QUOSA across 11 years, from founding to its latest funding, stage changes and deals.
- Founded QUOSA is founded.
- Exit Acquired by Elsevier.
Competitors of QUOSA
QUOSA operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Inato, goBalto, NoviSci, Acme Clinical Trials and Clinata, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| inato.com | 2016 | Paris, France | $35.52M | – | AI-based patient recruitment platform | |
| gobalto.com | 2008 | San Francisco, United States | $38.25M | 66 | Cloud-based SaaS solutions for clinical trial startup are offered. | |
| novisci.com | 2016 | Durham, United States | – | – | Provider of an online scientific sourcing tool for researchers and professionals | |
| aclinicaltrials.com | 2017 | San Jose, United States | – | – | Provides an online database of clinical trial studies for researchers. | |
| clinata.com | 2012 | Dallas, United States | $100,000 | – | Online Clinical Research Marketplace | |
| altavoice.com | 2004 | San Mateo, United States | – | – | Patient Insight Network (PIN) helping drug developers find better treatments for diseases | |
| dementiasplatform.uk | 2014 | Oxford, United Kingdom | – | – | Platform for dementia research, data access, and clinical trials collaboration. | |
| doctorpenguin.com | 2019 | United States | – | – | Provides an online platform with comprehensive health information for COVID-19. |
Detailed competitors of QUOSA
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to QUOSA
10 companies that operate in the same segment as QUOSA (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about QUOSA
QUOSA was founded in 2001.
QUOSA is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
QUOSA was founded in 2001 and is based in Waltham, United States, as part of Elsevier Life Science Solutions. Software solutions are offered to support literature management workflows in pharmaceutical and life-science sectors. Retrieval, organization, and sharing of scientific literature are facilitated through integrations with databases such as Embase, ScienceDirect, and PubMed. Pharmacovigilance operations are enhanced to promote patient safety within organizations.
QUOSA has 1 investor. Key investors include Elsevier.
QUOSA operates through Quosa Inc.
Yes. QUOSA was acquired by Elsevier in January 2012.